Skip to main content

Table 3 Comparison of post-70-GS treatment recommendations prior to and following publication of MINDACT results, proportions of recommendations concordant or discordant with 70-GS results

From: MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

Timing of Treatment Recommendations

Concordance of Treatment Recommendations with 70-GS Results

 

All Patients

Concordant

Discordant

Total

p-value

 Pre-MINDACT

91 (84.3%)

17 (15.7%)

108

p = 0.094

 Post-MINDACT

226 (90.4%)

24 (9.6%)

250

70-GS Low Risk Patients

 Pre-MINDACT

55 (88.7%)

7 (11.3%)

62

p = 0.351

 Post-MINDACT

150 (92.6%)

12 (7.4%)

162

70-GS High Risk Patients

 Pre-MINDACT

36 (78.3%)

10 (21.7%)

46

p = 0.229

 Post-MINDACT

76 (86.3%)

12 (13.6%)

88